News

ALS News Today3h
Klotho advances ALS gene therapy KLTO‑202 to manufacturing phase
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...
BioSpace3h
ALS Patients Petition FDA To Reconsider BrainStorm’s NurOwn, Pointing to Recent Survival Data
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...
BrainStorm Cell Therapeutics Inc.: FDA Review of Citizen Petition Offers a Fresh Look at NurOwn's Evidence of Treatment Effectiveness
BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS NEW YORK, July 8, 2025 /PRNewswire/ -- BrainStorm ...
FDA Review of Citizen Petition Offers a Fresh Look at NurOwn®'s Evidence of Treatment Effectiveness
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
Daijiworld7h
Common anxiety, depression and sleep medications linked to higher ALS risk: Study
A new study published in JAMA Neurology suggests that commonly prescribed medications for anxiety, depression, and sleep ...
Anxiety, depression and sleep medicines linked to higher risk of neurological disease
A new study links common mental health drugs to a higher ALS risk. The research focused on anxiolytics, hypnotics, and ...
Anxiety, depression and sleep meds may increase risk of rare neuro disease
Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...